Vimentin serum biomarkers are differentially related to disease progression in idiopathic pulmonary fibrosis (IPF)

被引：0
|
作者：
Simoes, Filipa B. [1 ]
Hoyer, Nils [2 ]
Prior, Thomas S. [3 ]
Jessen, Henrik [1 ]
Fredriksen, Peder [1 ]
Karsdal, Morten [1 ]
Leeming, Diana J. [1 ]
Bendstrup, Elisabeth [4 ]
Sand, Jannie M. B. [1 ]
Shaker, Saher B. [2 ]
机构：
[1] Nord Biosci, Herlev, Denmark
[2] Herlev & Gentofte Univ Hosp, Dept Resp Med, Copenhagen, Denmark
[3] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Ctr Rare Lung Dis, Aarhus, Denmark
[4] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA4060
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BIOMARKERS CAN PREDICT DISEASE PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS: ANALYSIS FROM THE AUSTRALIAN IPF REGISTRY
    Jo, Helen E.
    Corte, Tamera J.
    Glaspole, Ian
    Grainge, Christopher
    Goh, Nicole
    Hopkins, Peter Ma
    Reynolds, Paul N.
    Chapman, Sally
    Walters, E. Haydn
    Zappala, Christopher
    Allan, Heather
    Keir, Gregory J.
    Hayen, Andrew
    Cooper, Wendy A.
    Mahar, Annabelle M.
    Ellis, Samantha
    Macansh, Sacha
    Moodly, Yuben
    RESPIROLOGY, 2017, 22 : 78 - 78
  • [2] Biomarkers Can Predict Disease Progression In Idiopathic Pulmonary Fibrosis: Analysis From The Australian Ipf Registry
    Jo, H. E.
    Corte, T. J.
    Glaspole, I.
    Grainge, C.
    Goh, N. S.
    Hopkins, P.
    Reynolds, P.
    Chapman, S.
    Walters, E. H.
    Zappala, C.
    Allan, H.
    Keir, G.
    Hayen, A.
    Cooper, W.
    Mahar, A.
    Ellis, S.
    Macansh, S.
    Moodley, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
    Zhu, Weiwei
    Liu, Chunquan
    Tan, Chunting
    Zhang, Jie
    HELIYON, 2024, 10 (01)
  • [4] Prognostic Value of Serum Biomarkers in Patients with Idiopathic Pulmonary Fibrosis in Relation to Disease Progression
    Domvri, Kalliopi
    Organtzis, Ioannis
    Apostolopoulos, Apostolos
    Fouka, Evangelia
    Kontakiotis, Theodoros
    Papakosta, Despoina
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (09):
  • [5] Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis
    Inchingolo, Riccardo
    Varone, Francesco
    Sgalla, Giacomo
    Richeldi, Luca
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (01) : 39 - 51
  • [6] Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF)
    Chien, Jason
    Shao, Lixin
    Lyman, Susan
    Adamkewicz, Joanne
    Smith, Victoria
    O'Riordan, Thomas
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [7] Endotrophin is related to disease progression in idiopathic pulmonary fibrosis
    Jessen, Henrik
    Hoyer, Nils
    Ronnow, Sarah
    Karsdal, Morten
    Leeming, Diana
    Sand, Jannie
    Shaker, Saher
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [8] Serum biomarkers in idiopathic pulmonary fibrosis
    van den Blink, Bernt
    Wijsenbeek, Marlies S.
    Hoogsteden, Henk C.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (06) : 515 - 520
  • [9] Serum biomarkers in idiopathic pulmonary fibrosis
    Patrucco, Filippo
    Bellan, Mattia
    Solidoro, Paolo
    PANMINERVA MEDICA, 2021, 63 (02) : 199 - 200
  • [10] MULITPLE PROGRESSION EVENTS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Nathan, S.
    Costabel, U.
    Glaspole, I
    Glassberg, M.
    Lancaster, L.
    Lederer D, J.
    Pereira C, A.
    Trzaskoma, B.
    Limb, S.
    Wells A, U.
    RESPIROLOGY, 2018, 23 : 102 - 102
12345